The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Parkinson’s Disease Therapeutics Pipeline Program, 2024Development of Brain-penetrant TrkB Agonist Antibody for Parkinson’s Disease
Study Rationale: Parkinson's disease (PD) is characterized by the death of dopamine neurons, which control movement. We have generated a novel therapeutic agent — an antibody that activates a receptor...
-
Research Grant, 2024Quantification of Three Previously Identified Biomarkers of Progression in Stage 2/3 of Parkinson’s Disease
Study Rationale: Early indicators for Parkinson’s disease (PD), so-called biomarkers, are needed to identify subjects at risk during the earliest, prodromal stages of disease and to support clinical...
-
Research Grant, 2024Measurement of Phosphorylated Alpha-synuclein in Skin Biopsies as a Prospective Biomarker for Parkinson’s Disease
Study Rationale: Parkinson’s disease (PD) is associated with an accumulation of phosphorylated alpha-synuclein, and the amount of the protein increases as PD progresses. We have found that we can...
-
Research Grant, 2024Developing Community Health Worker Remote Training Modules on Research, Brain Health and Parkinson’s Disease
Study Rationale: Neurodegenerative diseases including Parkinson's disease (PD) disproportionately impact underserved communities due to barriers in research participation and awareness. Community...
-
ASAP 2020, 2024Parkinson5D: Deconstructing Disease Mechanisms Across Cells, Space and Disease Progression
Study Rationale: Genome-wide association studies (GWAS) have unequivocally linked thousands of genetic variants to susceptibility for common, genetically complex Parkinson’s disease (PD), which...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2024Investigating Oxygen Limitation (Hypoxia) as a Novel Treatment for Parkinson’s Disease
Study Rationale: Non-pharmacological interventions can benefit human health, and anecdotal evidence suggest that people with Parkinson’s disease (PD) show fewer symptoms when traveling at high...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.